Compounds > tolvaptan
Page last updated: 2024-09-05

tolvaptan and Paraneoplastic Syndromes

tolvaptan has been researched along with Paraneoplastic Syndromes in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Koch, M; Schulz, C; Utpatel, K1
Angelini, C; Arosio, P; Bertuzzi, A; Colombo, P; Cucchiari, D; De Sanctis, R; Faucher, E; Fusco, N; Pellegrinelli, A1
Giuliani, C; Peri, A1
Hiddemann, W; Schnaiter, A1
Blau, W; Brock, J; Gattenlöhner, S; Karrasch, T; Nilles, M; Roller, FC; Roller, FF; Schäffler, A; Steiner, D1

Reviews

1 review(s) available for tolvaptan and Paraneoplastic Syndromes

ArticleYear
Management of euvolemic hyponatremia attributed to SIADH in the hospital setting.
    Minerva endocrinologica, 2014, Volume: 39, Issue:1

    Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Blood Volume; Body Water; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Demeclocycline; Diabetes Insipidus, Nephrogenic; Disease Management; Drug Interactions; Hospitalization; Humans; Hydrocortisone; Hyponatremia; Hypothyroidism; Inappropriate ADH Syndrome; Kidney Tubules, Collecting; Lithium; Multicenter Studies as Topic; Osmolar Concentration; Paraneoplastic Syndromes; Saline Solution, Hypertonic; Tolvaptan

2014

Other Studies

4 other study(ies) available for tolvaptan and Paraneoplastic Syndromes

ArticleYear
[Hyponatremia in a 58-year-old female patient with EGFR-positive lung adenocarcinoma].
    Der Internist, 2018, Volume: 59, Issue:4

    Topics: Adenocarcinoma of Lung; Afatinib; Biopsy; Bronchoscopy; Cell Transformation, Neoplastic; Disease Progression; DNA Mutational Analysis; DNA-Binding Proteins; ErbB Receptors; Female; Humans; Hyponatremia; Lung; Lung Neoplasms; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Paraneoplastic Syndromes; Small Cell Lung Carcinoma; Tolvaptan; Tomography, X-Ray Computed; Transcription Factors

2018
Juxtaglomerular cell tumor: multicentric synchronous disease associated with paraneoplastic syndrome.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013, May-10, Volume: 31, Issue:14

    Topics: Antidiuretic Hormone Receptor Antagonists; Antineoplastic Combined Chemotherapy Protocols; Benzazepines; Dacarbazine; Deoxycytidine; Diagnosis, Differential; Disease Progression; Doxorubicin; Gemcitabine; Humans; Hyponatremia; Ifosfamide; Immunohistochemistry; Immunophenotyping; Inappropriate ADH Syndrome; Juxtaglomerular Apparatus; Kidney Neoplasms; Luminescent Measurements; Male; Middle Aged; Neoplasms, Multiple Primary; Paclitaxel; Paraneoplastic Syndromes; Renin; Tolvaptan; Vinblastine; Vinorelbine

2013
[Symptomatic therapy of SIADH in small cell lung cancer by tolvaptan].
    Deutsche medizinische Wochenschrift (1946), 2014, Volume: 139, Issue:41

    Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Female; Humans; Inappropriate ADH Syndrome; Lung Neoplasms; Paraneoplastic Syndromes; Small Cell Lung Carcinoma; Tolvaptan; Treatment Outcome

2014
[77-year-old female with hyponatremia, pruritus and papulous exanthema].
    Deutsche medizinische Wochenschrift (1946), 2015, Volume: 140, Issue:13

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Benzazepines; Diagnosis, Differential; Disease Progression; Exanthema; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Lymphoma, T-Cell, Cutaneous; Multimodal Imaging; Paraneoplastic Syndromes; Positron-Emission Tomography; Pruritus; Tolvaptan; Tomography, X-Ray Computed

2015